Open access · CC-BY
via OpenAlex
Rasagiline Ameliorates Olfactory Deficits in an Alpha-Synuclein Mouse Model of Parkinson's Disease
Géraldine H. Petit, Elijahu Berkovich, Mark S. Hickery, Pekka Kallunki, Karina Fog, Cheryl J. Fitzer‐Attas, Patrik Brundin
PLoS ONE · 2013 · ▲ 38 citations
Abstract
Impaired olfaction is an early pre-motor symptom of Parkinson's disease. The neuropathology underlying olfactory dysfunction in Parkinson's disease is unknown, however α-synuclein accumulation/aggregation and altered neurogenesis might play a role. We characterized olfactory deficits in a transgenic mouse model of Parkinson's disease expressing human wild-type α-synuclein under the control of the mouse α-synuclein promoter. Preliminary clinical observations suggest that rasagiline, a monoamine oxidase-B inhibitor, improves olfaction in Parkinson's disease. We therefore examined whether rasagiline ameliorates olfactory deficits in this Parkinson's disease model and investigated the role of olfactory bulb neurogenesis. α-Synuclein mice were progressively impaired in their ability to detect odors, to discriminate between odors, and exhibited alterations in short-term olfactory memory. Rasagiline treatment rescued odor detection and odor discrimination abilities. However, rasagiline did not affect short-term olfactory memory. Finally, olfactory changes were not coupled to alterations in olfactory bulb neurogenesis. We conclude that rasagiline reverses select olfactory deficits in a transgenic mouse model of Parkinson's disease. The findings correlate with preliminary clinical observations suggesting that rasagiline ameliorates olfactory deficits in Parkinson's disease.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1371/journal.pone.0060691
- Canonical
- link ↗
- Fetched
- 2026-10-21 MST
Cite this
APA
Petit, G.H., Berkovich, E., Hickery, M.S., Kallunki, P., Fog, K., Fitzer‐Attas, C.J., & Brundin, P. (2013). Rasagiline Ameliorates Olfactory Deficits in an Alpha-Synuclein Mouse Model of Parkinson's Disease. <em>PLoS ONE</em>. https://doi.org/10.1371/journal.pone.0060691
Vancouver
Petit GH, Berkovich E, Hickery MS, Kallunki P, Fog K, Fitzer‐Attas CJ, et al. Rasagiline Ameliorates Olfactory Deficits in an Alpha-Synuclein Mouse Model of Parkinson's Disease. PLoS ONE. 2013. doi:10.1371/journal.pone.0060691.
BibTeX
@article{graldine2013Rasagi,
title = {Rasagiline Ameliorates Olfactory Deficits in an Alpha-Synuclein Mouse Model of Parkinson's Disease},
author = {Géraldine H. Petit and Elijahu Berkovich and Mark S. Hickery and Pekka Kallunki and Karina Fog and Cheryl J. Fitzer‐Attas and Patrik Brundin},
journal = {PLoS ONE},
year = {2013},
doi = {10.1371/journal.pone.0060691},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Movement Disorders 2010
Preprint · OA
Staging of α‐synuclein in the olfactory bulb in a model of Parkinson's disease: Cell types involved
Progress in Lipid Research 2010
Citation only
Alpha-synuclein, lipids and Parkinson’s disease
PLoS ONE 2014
Open access · CC-BY
Olfactory Deficits in an Alpha-Synuclein Fly Model of Parkinson’s Disease
Neurobiology of Disease 2015
Preprint · OA
Severely impaired hippocampal neurogenesis associates with an early serotonergic deficit in a BAC α-synuclein transgenic rat model of Parkinson's disease
BMB Reports 2021
Open access · CC-BY
Olfactory neuropathology in Alzheimer's disease: a sign of ongoing neurodegeneration
Translational Neurodegeneration 2018
Open access · CC-BY